Short-term anti-CD4 plus anti-TNF-α receptor treatment in allogeneic small bowel transplantation results in long-term survival

Transplantation

Volumn 84, Issue 5, 2007, Pages 639-646

  Langrehr, Jan M ^a   Gube, Kathrin ^a   Hammer, Markus H ^a   Lehmann, Manfred ^b   Polenz, Dietrich ^a   Pascher, Andreas ^a   Volk, Hans Dieter ^a   Reinke, Petra ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Anti CD4 antibody; Anti TNF antibody; Intestinal transplantation; Rat

Indexed keywords

ETANERCEPT; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCLONAL ANTIBODY; RIB5 MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; GENE EXPRESSION; GRAFT SURVIVAL; HISTOLOGY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE TRANSPLANTATION; LEWIS RAT; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SHORT COURSE THERAPY; SURVIVAL TIME;

ANIMALS; ANTIBODIES; ANTIGENS, CD4; BODY WEIGHT; CELL SURVIVAL; GRAFT SURVIVAL; INTESTINE, SMALL; LYMPHOCYTES; RATS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RNA, MESSENGER; SURVIVAL RATE; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34548775803     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000280552.85779.d7     Document Type: Article

References (54)

1. Elia M. An international perspective on artificial nutritional support in the community. Lancet 1995; 345: 1345.
2. Langnas AN. Advances in small-intestine transplantation. Transplantation 2004; 77: 75.
3. Pascher A, Klupp J, Schulz RJ, et al. Klinische Ergebnisse der Dünndarm- und Multiviszeraltransplantation an der Berliner Charité. Dtsch Med Wochenschr 2005; 130: 387.
4. Fryer JP. Intestinal transplantation: an update. Curr Opin Gastroenterol 2005; 21: 162.
5. Wu T, Bond G, Martin D, et al. Histopathologic characteristics of human intestine allograft acute rejection in patients pretreated with thymoglobulin or alemtuzumab. Am J Gastroenterol 2006; 101: 1617.
6. Beath SV. Closure and summary of ninth international small bowel transplantation symposium. Transplant Proc 2006; 38: 1657.
7. Abreu-Martin M, Targan SR. Regulation of immune responses of the intestinal mucosa. Crit Rev Immunol 1996; 16: 277.
8. Rosemurgy AS, Schraut WH. Small bowel allografts. Sequence of histologic changes in acute and chronic rejection. Am J Surg 1986; 151: 470.
9. Langrehr JM, Demetris AJ, Banner B, et al. Mucosal recipient-type mononuclear repopulation and low-grade chronic rejection occur simultaneously in indefinitely surviving recipients of small bowel allografts. Transpl Int 1994; 7: 71.
10. Grant D, Zhong R, Gunn H, et al. Graft-versus-host disease associated with intestinal transplantation in the rat: Host immune function and general histology. Transplantation 1989; 48: 545.
11. Jamieson NV, Joysey V, Friend PJ, et al. Graft-versus-host disease in solid organ transplantation. Transpl Int 1991; 4: 67.
12. Langrehr JM, Hoffman RA, Banner B, et al. Induction of graft-versus-host disease and rejection by sensitized small bowel allografts. Transplantation 1991; 52: 399.
13. Müller AR, Langrehr JM, Nalesik M, et al. Mucosal glutaminase activity and histology as parameters of small bowel preservation injury. J Surg Res 1994; 56: 207.
14. Nüssler NC, Müller AR, Weidenbach H, et al. IL-10 increases tissue injury after selective intestinal ischemia/reperfusion. Ann Surg 2003; 238: 49.
15. Moon JI, Tzakis AG. Intestinal and multivisceral transplantation. Yonsei Med J 2004; 45: 1101.
16. Fishbein TM, Kaufman SS, Florman SS, et al. Isolated intestinal transplantation: proof of clinical efficacy. Transplantation 2003; 76: 636.
17. Garcia M, Weppler D, Mittal N, et al. Campath-1 Immunosuppressive therapy reduces incidence and intensity of acute rejection in intestinal and multivisceral transplantation. Transplant Proc 2004; 36: 323.
18. Iyer KR, Srinath C, Horslen S, et al. Late graft loss and long-term outcome after isolated intestinal transplantation in children. J Pediatr Surg 2002; 37: 151.
19. Kato T, Gaynor JJ, Selvaggi G, et al. Intestinal transplantation in children: A summary of clinical outcomes and prognostic factors in 108 patients from a single center. J Gastrointest Surg 2005; 9: 75.
20. Wood KJ. New concepts in tolerance. Clin Transplant 1996; 10: 93.
21. Starzl TE. Chimerism and tolerance in transplantation. PNAS 2004; 101(II): 14607-14614.
22. Cobbold SP, Adams E, Marschall SE, et al. Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. Immunol Rev 1996; 149: 5.
23. Waldmann H, Bemelman F, Cobbold S. Tolerance induction with CD4 monoclonal antibodies. Novartis Found Symp 1998; 215: 146.
24. Morelli AE, Thomson AW. Role of dendritic cells in the immune response against allografts. Curr Opin Nephrol Hypertens 2000; 9: 607.
25. Lehmann M, Graser E, Risch K, et al. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells. Transplantation 1997; 64: 1181.
26. Onodera K, Lehmann M, Akalin E, et al. Induction of " infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. J Immunol 1996; 157: 1944.
27. Kimizuka K, Nakao A, Nalesnik MA, et al. Exogenous IL-6 inhibits acte inflammatory responses and prevents ischemia/reperfusion injury after intestinal transplantation. Am J Transplant 2004; 4: 482.
28. Brown SJ, Abreu MT. Antibodies to tumor necrosis factor-alpha in the treatment of Crohn's disease. Curr Opin Drug Discov Devel 2005; 8: 160.
29. Gill TJ III, Kunz HW, Misra DN, Cortese-Hassett AL. The major histocompatibility complex of the rat. Transplantation 1987; 43: 773.
30. Langrehr JM, Banner B, Lee KKW, Schraut WH. Clinical course, morphology and treatment of chronically rejecting small bowel allografts. Transplantation 1993; 55: 242.
31. Langrehr JM, Machens C, Zill E, et al. Bacterial translocation during graft-versus-host disease after small bowel transplantation is reduced following inhibition of inducible nitric oxide synthesis. Transplantation 2000; 69: 2415.
32. Kotsch K, Mashreghi MF, Bold G, et al. Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection. Transplantation 2004; 77: 1866.
33. Cobbold SP, Castejon R, Adams E, et al. Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J Immunol 2004; 172: 6003.
34. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057.
35. Gould DS, Auchincloss H Jr. Direct and indirect recognition: The role of MHC antigens in graft rejection. Immunol Today 1999; 20: 77.
36. Butcher GW. A list of monoclonal antibodies specific for alloantigens of the rat. J Immunogenet 1987; 14: 163.
37. Onodera K, Lehmann M, Volk HD, et al. CD4-targeted therapy induces "infectious" tolerance to cardiac allografts in sensitized rat recipients. Transplant Proc 1997; 29: 1907.
38. Langrehr JM, Hoffman RA, Demetris AJ, et al. Evidence that indefinite survival of small bowel allografts achieved by a brief course of cyclosporine or FK506 is not due to systemic hyporesponsiveness. Transplantation 1992; 54: 505.
39. Yin DP, Sankary HN, Williams J, et al. Induction of tolerance to small bowel allografts in high-responder rats by combining anti-CD4 with CTLA4Ig. Transplantation 1996; 62: 1537.
40. Adam R, Bismuth H, Diamond T, et al. Effect of extended cold ischaemia with UW solution on graft function after liver transplantation. Lancet 1992; 340: 1373.
41. Porte RJ, Ploeg RJ, Hansen B, et al. Long-term graft survival after liver transplantation in the UW era: Late effects of cold ischemia and primary dysfunction. European Multicentre Study Group. Transpl Int 1998; 11: 164.
42. Kato A, Gabay C, Okaya T, Lentsch AB. Specific role of interleukin-1 in hepatic neutrophil recruitment after ischemia/reperfusion. Am J Pathol 2002; 161: 1797.
43. Reinecker HC, Steffen M, Witthoeft T, et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993; 94: 174.
44. Van den Brande J, Hommes DW, Peppelenbosch MP. Infliximab induced T lymphocyte apoptosis in Crohn's disease. J Rheumatol 2005; 74: 26.
45. Tarumi K, Murakami M, Yagihashi A, et al. CTLA4IgG treatment induces long-term acceptance of rat small bowel allografts. Transplantation 1999; 67: 520.
46. Drakes ML, Zahorchak AF, Takayama T, et al. Chemokine and chemokine receptor expression by liver derived denditric cells: MIP-1alpha production is induced by bacterial lipopolysaccharide and interaction with allogeneic T cells. Transplant Immunol 2000; 8: 17.
47. Ajuebor MN, Hogaboam CM, Le T, et al. CCL3/MIP-1alpha is proinflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver. Eur J Immunol 2004; 34: 2907.
48. Ottonello L, Montecucco F, Bertolotto M, et al. CCL3 (MIP-1alpha) induces in vitro migration of GM-CSF-primed human neutrophils via CCR5-dependent activation of ERK 1/2. Cell Signal 2005; 17: 355.
49. Pietra BA, Wiseman A, Bolwerk A, et al. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J Clin Invest 2000; 106: 1003.
50. Larsen CP, Austyn JM, Morris PJ. The role of graft-derived dendritic leukocytes in the rejection of vascularized organ allografts. Recent findings on the migration and function of dendritic leukocytes after transplantation. Ann Surg 1990; 212: 308.
51. Lakkis FG. Where is the alloimmune response initiated? Am J Transplant 2003; 3: 241.
52. Pasare C, Morafo V, Entringer M, et al. Presence of activated antigen-binding B cells during immunization enhances relative levels of IFN-gamma in T cell responses. J Immunol 1998; 160: 778.
53. Rivera A, Chen CC, Ron N, et al. Role of B cells as antigen-presenting cells in vivo revisited: Antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations. Int Immunol 2001; 13: 1583.
54. Hollsberg P, Batra V, Dressel A, Hafler DA. Induction of anergy in CD8 T cells by B cell presentation of antigen. J Immunol 1996; 157: 5269.